Novartis Ag (NVS) Return on Invested Capital [ROIC] (2009 - 2026)
Novartis Ag (NVS) posted Return on Invested Capital [ROIC] of 34.87% for Q2 2026, up 0.34 percentage points from 34.53% a year earlier and up 0.23 percentage points from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends
For FY2025, Novartis Ag's Return on Invested Capital [ROIC] came in at 28.48%, up 4.43 percentage points from FY2024.
- Annual Return on Invested Capital [ROIC] has increased for three consecutive years, with a five-year change of +15.79 percentage points (FY2020 to FY2025).
- In prior years, Novartis Ag's Return on Invested Capital [ROIC] was 24.05% in FY2024 (+7.73 pp), 16.31% in FY2023 (+6.83 pp), 9.48% in FY2022 (-3.70 pp) and 13.18% in FY2021 (+0.49 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Invested Capital [ROIC] in data going back to Q1 2009.
- On a year-over-year basis, Return on Invested Capital [ROIC] has increased in each of the last 12 quarters, with an average year-over-year change of +7.13 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was Q1 2025, with a gain of 11.59 percentage points; the weakest was Q3 2022, with a drop of 4.46 percentage points.
- According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was 34.65% (Q1 2026), 33.57% (Q4 2025) and 34.21% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 38.16% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.88% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 24.11% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 12.34% |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.87% |
| Mar 31, 2026 | 34.65% |
| Dec 31, 2025 | 33.57% |
| Sep 30, 2025 | 34.21% |
| Jun 30, 2025 | 34.53% |
| Mar 31, 2025 | 31.91% |
| Dec 31, 2024 | 28.24% |
| Sep 30, 2024 | 26.88% |
| Jun 30, 2024 | 23.23% |
| Mar 31, 2024 | 20.32% |
| Dec 31, 2023 | 19.53% |
| Sep 30, 2023 | 17.21% |
| Jun 30, 2023 | 15.09% |
| Mar 31, 2023 | 13.45% |
| Dec 31, 2022 | 12.91% |
| Sep 30, 2022 | 13.72% |
| Jun 30, 2022 | 15.71% |
| Mar 31, 2022 | 16.91% |
| Dec 31, 2021 | 16.55% |
| Sep 30, 2021 | 18.18% |
API Access
Novartis Ag Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();